Literature DB >> 1371902

Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study.

G Sabini1, J C Chumas, W J Mann.   

Abstract

Seven cases of endometrial stromal sarcoma (five low grade and two high grade) were analyzed immunohistochemically for the presence of estrogen and progesterone receptors. In four cases (three low grade and one high grade), these results were compared to biochemical findings. All low-grade endometrial stromal sarcomas were positive for progesterone receptors using immunohistochemical techniques. These results correlated well with biochemical evaluation of progesterone receptors. The high-grade endometrial stromal sarcomas were negative for progesterone and estrogen receptors by both methods. The advantages of immunohistochemical evaluation of steroid receptors have been well established in breast and endometrial carcinomas. This study demonstrates the usefulness of this technique in endometrial stromal sarcomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371902     DOI: 10.1093/ajcp/97.3.381

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.

Authors:  Keiko Shoji; Katsutoshi Oda; Shunsuke Nakagawa; Kei Kawana; Toshiharu Yasugi; Yuji Ikeda; Yutaka Takazawa; Shiro Kozuma; Yuji Taketani
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

2.  Metastatic low-grade endometrial stromal sarcoma of the sigmoid colon three years after hysterectomy.

Authors:  Yuki Asada; Hajime Isomoto; Fumitaka Akama; Noriko Nomura; Chun-Yang Wen; Haruhiko Nakao; Ikuo Murata; Kan Toriyama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.

Authors:  Kentaro Nakayama; Masako Ishikawa; Yutaka Nagai; Nobuo Yaegashi; Yoichi Aoki; Khoji Miyazaki
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

4.  The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study.

Authors:  A C Ansink; P A Cross; P Scorer; A de Barros Lopes; J M Monaghan
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

5.  Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation.

Authors:  A N Cheung; W F Ng; L P Chung; U S Khoo
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

6.  Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.

Authors:  Farid Moinfar; Peter Regitnig; Ali Dastranj Tabrizi; Helmut Denk; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2004-03-06       Impact factor: 4.064

7.  Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.

Authors:  O Reich; S Regauer; W Urdl; M Lahousen; R Winter
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

8.  Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literature.

Authors:  Kohei Nakamura; Kentaro Nakayama; Masako Ishikawa; Noriyoshi Ishikawa; Hiroshi Katagiri; Atsuko Katagiri; Tomoka Ishibashi; Emi Sato; Kohji Iida; Razia Sultana; Satoru Kyo
Journal:  Oncol Lett       Date:  2016-09-26       Impact factor: 2.967

Review 9.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.